Zur Rose and Shop Apotheke dominate the EU market for online pharmacies and see potential in Germany despite its fierce protection of classic drugstores.
German relations with Saudi Arabia have been frosty for months, partly due to unfortunate comments made by a former foreign minister. Now Riyadh seems to have instituted a semi-official boycott of German companies.
A bitter US legal battle over a botched takeover has cast a shadow over German healthcare firm Fresenius and its separately listed cash cow, Fresenius Medical Care. That shouldn't stop it from seeking more acquisitions.
Generic drugs giant Stada has had a difficult year following a messy buyout. Its figures remain sound, but investors will pay the price with a slashed dividend.
German healthcare giant, Healthineers, will launch Germany’s biggest IPO in over 20 years. CEO Bernd Montag talks about his vision, potential future acquisitions and his management style in an exclusive interview.
Nursing home care is a growing market in Germany, but it is hampered by staff shortages, a lack of capital and a lot of red tape.
The world’s largest salt producer, K+S of Germany, embarked on a wide-ranging revamp in a bid to shore up earnings. For investors, there was little to relish.
As the deadline looms, shareholders are slow to back Bain and Cinven's second attempt to buy out the generic drugmaker. If the latest bid fails, unions say they will resist another attempt at a takeover.
The boss of Stada, a maker of generic drugs, claims he's confident the second takeover bid for his company will go through. But some shareholders could speculate for a better deal.
Hedge funds flock to the generic manufacturer as finance giants Bain and Cinven launch a second bid to acquire control.